Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Canales

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Neurology|August 28, 2013
Author ResponseRenaud A Du Pasquier, Mathieu Canales, Myriam Schluep
STAR Protocols|November 8, 2021
Differentiation of functional astrocytes from human-induced pluripotent stem cells in chemically defined mediaSylvain Perriot, Mathieu Canales, Amandine Mathias, et al.
STAR Protocols|August 29, 2022
Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditionsSylvain Perriot, Mathieu Canales, Amandine Mathias, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 26, 2016
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patientsAmandine Mathias, Guillaume Perriard, Mathieu Canales, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 10, 2016
Increased ex vivo antigen presentation profile of B cells in multiple sclerosisAmandine Mathias, Guillaume Perriard, Mathieu Canales, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 22, 2013
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patientsSamantha Jilek, Amandine Mathias, Mathieu Canales, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 28, 2017
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarateAmandine Mathias, Sylvain Perriot, Mathieu Canales, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2012
HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosisSamantha Jilek, Myriam Schluep, Alexandre Harari, et al.
Journal of Neuroinflammation|June 17, 2015
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytesGuillaume Perriard, Amandine Mathias, Lukas Enz, et al.
The Lancet. Neurology|February 2, 2010
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal studySamantha Jilek, Emilie Jaquiéry, Hans H Hirsch, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Neurology|August 28, 2013
Author ResponseRenaud A Du Pasquier, Mathieu Canales, Myriam Schluep
STAR Protocols|November 8, 2021
Differentiation of functional astrocytes from human-induced pluripotent stem cells in chemically defined mediaSylvain Perriot, Mathieu Canales, Amandine Mathias, et al.
STAR Protocols|August 29, 2022
Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditionsSylvain Perriot, Mathieu Canales, Amandine Mathias, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 26, 2016
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patientsAmandine Mathias, Guillaume Perriard, Mathieu Canales, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 10, 2016
Increased ex vivo antigen presentation profile of B cells in multiple sclerosisAmandine Mathias, Guillaume Perriard, Mathieu Canales, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 22, 2013
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patientsSamantha Jilek, Amandine Mathias, Mathieu Canales, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 28, 2017
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarateAmandine Mathias, Sylvain Perriot, Mathieu Canales, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2012
HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosisSamantha Jilek, Myriam Schluep, Alexandre Harari, et al.
Journal of Neuroinflammation|June 17, 2015
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytesGuillaume Perriard, Amandine Mathias, Lukas Enz, et al.
The Lancet. Neurology|February 2, 2010
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal studySamantha Jilek, Emilie Jaquiéry, Hans H Hirsch, et al.
Pageof 2